ID   TE-85-SF
AC   CVCL_YE14
DR   cancercelllines; CVCL_YE14
DR   Wikidata; Q98133214
RX   PubMed=6575958;
CC   Group: Serum/protein free medium cell line.
CC   Population: Caucasian.
CC   Sequence variation: Gene deletion; HGNC; 1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; 11998; TP53; Simple; p.Arg156Pro (c.467G>C); ClinVar=VCV000634768; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Bone, right femur; UBERON=UBERON_0000981.
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0439 ! MNNG/HOS Cl #5
SX   Female
AG   13Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 05-10-23; Version: 10
//
RX   PubMed=6575958; DOI=10.1007/BF02619599;
RA   Tsang K.-Y., Fudenberg H.H., Sun D.C., Pai G.S., Bishop L.R., Sager S.;
RT   "Cultivation of human osteosarcoma cell lines in serum-free hormone
RT   supplemented medium.";
RL   In Vitro 19:515-521(1983).
//